Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1292523
                    [Title] => Chelsea Therapeutics blood pressure drug approved
                    [Summary] => 
The Food and Drug Administration on Tuesday approved a new drug from Chelsea Therapeutics to treat a rare blood pressure disorder that causes dizziness and fainting in patients with Parkinson's disease and similar conditions.

                    [DatePublished] => 2014-02-20 04:42:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1510054
                    [AuthorName] => Matthew Perrone
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

        )

)

NORTHERA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1292523
                    [Title] => Chelsea Therapeutics blood pressure drug approved
                    [Summary] => 
The Food and Drug Administration on Tuesday approved a new drug from Chelsea Therapeutics to treat a rare blood pressure disorder that causes dizziness and fainting in patients with Parkinson's disease and similar conditions.

                    [DatePublished] => 2014-02-20 04:42:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 1510054
                    [AuthorName] => Matthew Perrone
                    [SectionName] => World
                    [SectionUrl] => world
                    [URL] => 
                )

        )

)

abtest

Chelsea Therapeutics blood pressure drug approved

By Matthew Perrone | February 20, 2014 - 4:42am

The Food and Drug Administration on Tuesday approved a new drug from Chelsea Therapeutics to treat a rare blood pressure disorder that causes dizziness and fainting in patients with Parkinson's disease and similar...

World